Market revenue in 2023 | USD 56.5 million |
Market revenue in 2030 | USD 86.8 million |
Growth rate | 6.3% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | System and Technology Support Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.85% in 2023. Horizon Databook has segmented the Canada clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
The clinical trial imaging market in Canada is expected to grow significantly over the forecast period. The Health Canada manages the clinical trial database and provides a source of information about clinical trials in the country. Health Canada is the federal regulator accountable for authorizing the importation and sales of drugs for clinical trials.
This accountability is achieved by reviewing clinical trial applications for Phase I to III clinical trials, filed by sponsors of clinical trials. One of the objectives of Health Canada’s review is to determine that subjects contributing to the trial will not be exposed to unnecessary risks.
Health Canada approves nearly 900 clinical trials every year. Canada is known for the quality & expertise of its research clinicians. Most of them are universally recognized for key innovations & discoveries in the medical field and the ability to perform clinical research in difficult therapeutic areas with a large population base.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into Canada clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account